Literature DB >> 3037990

Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues.

N Bresolin, M Moggio, L Bet, A Gallanti, A Prelle, E Nobile-Orazio, L Adobbati, C Ferrante, G Pellegrini, G Scarlato.   

Abstract

We report biochemical, immunological, and morphological findings in a patient with fatal Kearns-Sayre syndrome. Histochemical and biochemical findings from muscle biopsy specimens obtained 7 years apart documented the disease's evolution from a mild mitochondrial disorder affecting a small proportion of muscle fibers to a severe disorder affecting a large proportion of muscle fibers. Cytochrome c oxidase activity in muscle declined profoundly as the disease progressed, although the level of enzyme protein was normal, as shown by immunochemical techniques. Other organs were severely affected by the disease. Examination of postmortem tissue showed spongiosis in the frontal cortex, diffuse loss of Purkinje cells in the cerebellum, liver steatosis, and heart fibrosis with mitochondrial abnormalities. Cytochrome c oxidase activity was only slightly reduced in these organs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037990     DOI: 10.1002/ana.410210607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Regulation of mitochondrial biogenesis in muscle by endurance exercise.

Authors:  Isabella Irrcher; Peter J Adhihetty; Anna-Maria Joseph; Vladimir Ljubicic; David A Hood
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Detection of the A to G(3243) mutation of mitochondrial DNA in Japanese families with mitochondrial encephalomyopathies.

Authors:  K Inui; H Tsukamoto; H Fukushima; M Taniike; J Tanaka; T Nishigaki; S Okada
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Neuropathology in Kearns-Sayre syndrome.

Authors:  A Oldfors; I M Fyhr; E Holme; N G Larsson; M Tulinius
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Cytochrome c oxidase and coenzyme Q in neuromuscular diseases: a histochemical study.

Authors:  C Doriguzzi; L Palmucci; B Pollo; T Mongini; M Maniscalco; L Chiadò-Piat; D Schiffer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients.

Authors:  A Lindner; E Hofmann; M Naumann; G Becker; H Reichmann
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

6.  Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency.

Authors:  C Doriguzzi; L Palmucci; T Mongini; N Bresolin; L Bet; G Comi; R Lala
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

7.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

8.  Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome.

Authors:  S Mita; B Schmidt; E A Schon; S DiMauro; E Bonilla
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Rapid quantitative immunohistochemical assessment of human peripheral neuropathies using a monoclonal antibody against nerve growth factor receptor.

Authors:  E Scarpini; S Beretta; A H Ross; M Moggio; S Jann; D Pleasure; G Scarlato
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

10.  Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases.

Authors:  L Bet; M Moggio; G P Comi; C Mariani; A Prelle; N Checcarelli; A Bordoni; N Bresolin; E Scarpini; G Scarlato
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.